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Point of Care Testing for C-Reactive Protein in Acute Cough Presentations: 
Feasibility, Efficacy, Benefits and Limitations 
 
Acute cough is one of the most common illnesses in the UK with an estimated 48 
million cases per annum (Morice, McGarvey, Pavord, 2006). The majority of these 
presentations are thought to be of viral aetiology and self-limiting in nature 
(Woodhead et al, 2011), yet Meropol, Localio and Metlay (2013) report antibiotic 
prescription rates of approximately 65% in the UK. Clincians’ decision-making 
process can be influenced by both patient expectations and difficulty in differentiating 
between viral and bacterial aetiologies by clinical examination alone. Despite 
warnings about antimicrobial resistance (AMR) from the World Health Organisation 
(WHO, 2011) clinicians in the UK continue to have high prescription rates for acute 
cough presentations in comparison to other developed health care systems (Cooke 
et al, 2015; Smith et al, 2014; Hawker et al, 2014). This article will consider the 
feasibility, efficacy, benefits and limitations of using point of care testing (POCT) of 
C-reactive protein (CRP) within primary care in the United Kingdom to help inform 
management of acute cough.  
Introduction 
 
Paramedics are being employed increasingly in diverse clinical areas. One such 
area is primary care, where General Practitioner (GP) surgeries employing 
paramedics to undertake urgent work and, in some cases, consult with patients in 
non-urgent appointments (Primary Care Workforce Comission 2014). The Primary 
Care Workforce Comission (2014) identifies that paramedics may have a key role to 
play, as part of a multidisciplinary team, in improving the delivery of primary care in 
GP surgeries. Ball (2005) highlighted that specialist paramedics were employed in 
minor injury units, intermediate care teams and in out-of-hours GP services 
delivering urgent, unscheduled care. It seems that this area of paramedic practice is 
growing rapidly and, as such, many paramedics now need to be aware of common 
illnesses among the population to tailor their repsonses to a changing healthcare 
system. 
 
Acute cough is one of the most common illnesses in the UK with an estimated 48 
million cases per annum (Morice, McGarvey, Pavord, 2006). It is defined as a cough 
lasting no longer than three weeks and is one of the most common reasons to seek 
medical advice in primary care (Morice, McGarvey, Pavord, 2006). Whilst the 
majority of acute cough presentations are benign and self-limiting, viral and bacterial 
infections of the respiratory tract have the potential to develop into more serious 
conditions such as Community Acquired Pneumonia (CAP). The majority of CAP 
patients can be safely managed in the community however a significant proportion 
will require more intensive treatment and mortality rates are estimated to be as high 
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as 7% (Cilloniz et al, 2011). In recent years there has been a notable trend to admit 
elderly patients to hospital who are diagnosed with CAP therefore early identification 
of the disease is considered important for targeted management in the community 
(Woodhead et al, 2011). This presents a challenge for clinicians who have to 
differentiate between benign self-limiting respiratory illness and more complex 
bacterial infection within a primary care setting.  
 
Whilst the precise aetiology is unknown it is believed that the majority of acute 
coughs are initially caused by viral nasopharyngitis, otherwise known as the common 
cold (Woodhead et al, 2011). In a healthy adult this condition is considered to be a 
benign and self-limiting virus therefore requiring minimal healthcare intervention at 
first presentation. In vitro studies have shown, however, that the initial viral infection 
creates favourable conditions for bacterial growth, making secondary bacterial 
infection more likely (Peltola and McCullers, 2004). The relationship between viral 
and bacterial respiratory tract infections (RTIs) is further emphasised by Cilloniz et al 
(2011) who identified 29% of pneumonias were of mixed viral and bacterial aetiology. 
It is therefore reasonable to assume that RTIs with mixed aetiology will present with 
a combination of viral and bacterial symptoms, making clinical diagnosis, and 
therefore targeted management, more problematic. This theory is well supported in 
the literature. Wipf et al (1999) and Metlay Kapoor and Fine (1997) both highlight the 
difficulty clinicians have in accurately diagnosing chest complaints with clinical signs 
and history alone. Additionally Hopstaken et al (2005) and Huijskens et al (2014) 
conclude in microbiological studies that there is significant overlap of symptoms for 
both viral and bacterial presentations of LRTI. From these studies we can surmise 
that clinicians’ ability to differentiate between bacterial LRTI, viral LRTI and bronchitis 
using clinical assessment and history taking alone is insufficient to accurately 
formulate a targeted management plan. This conclusion is supported in a recent 
comprehensive review commissioned by the European Respiratory Society (ERS) 
and The European Society for Clinical Microbiology and Infectious Diseases 
(ESCMID) (Woodhead et al, 2011). 
Acute Cough and Antibiotics 
Since 1964, anti-microbial resistance has been identified as one of the major threats 
to modern medicine prompting national governments and scientific communities to 
design strategies to combat AMR. In 2013 the UK Department of Health released a 
five year plan which identifies optimising prescribing practice as one of their main 
seven points of action (Department of Health, 2013). These sentiments are echoed 
at a continental and global level by the European Commission (EC, 2011) and World 
Health Organisation (WHO, 2011) highlighting the global threat posed by AMR. 
Additionally the Genomics to Combat Resistance against Antibiotics in Community 
Acquired Pneumonia (GRACE) has been specifically commissioned to focus on the 
management of patients with suspected lower respiratory tract infection (LRTI). 
Whilst the ambiguity of symptoms associated with acute cough presentations are 
considered a major factor in the over prescription of antibiotics (Woodhead et al, 
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2011), rising expectations of the patient has also been cited in the literature to 
contribute significantly. Coenen et al (2006) reports that GPs felt it was less 
appropriate to not prescribe antibiotics if the patient had requested it and McNulty et 
al (2013) demonstrated that 97% of patients who requested antibiotics from their GP 
received a prescription for their complaint. Additionally 23% of these prescriptions 
were prescribed without any further discussion about their illness with the doctor. 
While these are isolated studies, they raise questions about the current management 
strategies utilised by GPs when faced with demanding patients. Evidence suggests 
that patients are not well enough informed to make appropriate decisions regarding 
antibiotic prescriptions for acute cough symptoms (Cals et al, 2007; Coenen et al, 
2013). It is therefore essential to implement a more robust decision making strategy 
for primary care clinicians around in management of patients presenting with acute 
cough. 
 
CRP Testing as a Solution? 
The problematic diagnosis of pneumonia, increasing concern over AMR and high 
incidence of side effects associated with antibiotics, has prompted research into how 
modern health care systems can safely reduce antibiotic prescriptions for acute 
cough presentations. One of the methods being considered in the UK is the use of 
POCT for detecting raised C-reactive protein (CRP) in the patients blood. CRP is an 
acute phase reactant protein synthesised by the liver. It is produced in response to 
inflammation, infection or trauma as part of the immunological response (Riodan and 
McWilliam, 2009). Levels of CRP in blood serum begin to increase 4-6 hours after 
the initial insult or infection and peak after 36-50 hours (Riodan and McWilliam, 
2009). The technology to provide POCT for CRP is a relatively new development in 
primary care and has been shown to be equally as accurate as laboratory analysis 
by microbiologists (Seamark, Backhouse and Powell, 2003; Kotani et al, 2014). 
CRP testing has been used in hospital settings for the last fifty years to monitor 
patients with acute infections and their response to treatment (Cooke et al, 2015). Its 
successful utilisation in primary care for acute cough presentations will essentially 
depend on the test’s sensitivity and specificity in the diagnosis of CAP. Falk and 
Fahey (2009) conducted a comprehensive diagnostic accuracy systematic review of 
CRP in relation to CAP for patients both assessed in the community and emergency 
departments. They concluded that CRP measurements alone were insufficient to 
rule out CAP in a primary care setting, although they do concede that if the patient 
displays symptoms relating to CAP then CRP may have some diagnostic value. This 
is further qualified by Vugt et al (2013) who demonstrated patients with a CRP of 
under 20mg/L had a 3% chance of having radiographically confirmed pneumonia in 
primary care. This subgroup of patients were more likely to be on long term steroids 
which is known to reduce CRP readings (Vugt, 2013). In terms of ruling in CAP with 
CRP, Falk and Fahey (2009) report their findings were less clear in their meta-
analysis. Many of the studies that met the inclusion criteria were deemed to have 
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heterogenous data and therefore require further research prior to making any robust 
conclusions. Individual studies such as Almirall et al (2004), Bafadhel et al (2011), 
Muller et al (2007) and Espana et al (2012) do however demonstrate high 
sensitivities and specificities in diagnosing CAP patients presenting to emergency 
departments with varying cut off CRP levels. Guidelines published by both the 
GRACE consortium and the National Institute for Clinical Excellence (NICE) indicate 
that they concur with these conclusions, specifying that CRP of over 100 mg/L 
implies a high probability of CAP (Little et al, 2013; NICE, 2014). Despite these 
promising studies and acceptance by large institutions, it is of note that the majority 
of evidence for ruling in CAP has been conducted in a hospital setting. It may be 
presumed that patients presenting to emergency departments will have more severe 
symptoms than patients presenting in primary care increasing the overall probability 
of having CAP. This is highlighted by Vugt et al (2013) in one of the only studies to 
be conducted in primary care, who demonstrated that only 35 % of patients with 
CRP of over 100mg/L were later radiographically confirmed to have pneumonia. 
Further research is therefore needed in patients presenting in primary care to assess 
the validity of POCT CRP for ruling in CAP.   
POCT for CRP has already been introduced into primary health care systems in the 
Netherlands and Nordic countries to aid clinicians in their decision making in relation 
to acute cough symptoms (Cooke et al, 2015).  The majority of the research from 
these health care systems has focussed on how effective CRP tests are at reducing 
antibiotic prescriptions in primary care. In a relatively large cluster randomised 
control trial (RCT) in the Netherlands the use of CRP POCT was shown to reduce 
antibiotic prescriptions by 22% (Cals et al, 2009a). This study excluded patients seen 
at home or in nursing homes which resulted in a sample with a lower mean age than 
would normally have been expected. Whilst this subgroup of patients at home are 
more likely to be prescribed antibiotics due to their age and co-morbidities, the study 
still demonstrated a significant reduction of prescriptions for those attending the 
surgery. Little et al (2013) conducted a multinational study across several countries 
in Europe, including Great Britain, on behalf of the GRACE consortium. They were 
able to demonstrate a 15% reduction in antibiotic prescriptions after CRP POCT 
measurements were introduced into primary care. Further studies were included in a 
large meta-analysis by Huang et al (2013) showing a mean reduction of 18.9% in 
antibiotic prescriptions for patients assessed with CRP measurements. Whilst this is 
by far the largest meta-analysis conducted to date, the review has received criticism 
for several methodological flaws and therefore may not be sufficiently valid to draw 
any robust conclusions (Aabenhus, Cals and Jenson, 2014). Additionally the majority 
of the studies were conducted in European health care systems where it may be 
assumed that there would be cultural and educational differences to the United 
Kingdom that would affect antibiotic prescribing. It is important to note however that 
no significant adverse events, increase in mortality or admissions were reported in 
any of the trials, indicating that the use of CRP POCTs and reduction in antibiotic 
prescriptions may be safe in primary care. Conversely Engel et al (2011) questions 
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whether the evidence in primary care is valid enough to draw this conclusion, with 
several of the studies being methodologically flawed.  
Clinicians’ perspectives  
Whilst these studies show a significant reduction in antibiotic prescriptions clinicians 
have voiced concern about several aspects of CRP testing in primary care. Wood et 
al (2011) conducted a multi-country qualitative study to gather clinician and patient 
views in regards to POCT for CRP. The primary concerns for clinicians included 
questionable accuracy of tests and over reliance on CRP results, thereby detracting 
from the clinician’s clinical skills. Clincians were concerned about some of the 
limitaitons identified in the literature. CRP is known to increase during an infection, it 
also rises in response to inflammation and trauma, causing false positive results. 
Chronic diseases like crohns disease, osteoarthritis and rheumatoid arthritis are 
common examples where CRP is likely to be chronically raised, making 
interpretation of CRP results more problematic (Pepys and Hirschfields, 2003). 
Additionally CRP levels within the blood do not peak until 36-50 hours which could 
result in false negative results on initial presentation. False negative results are more 
of a concern as bacterial infection could be dismissed by the clinician on the basis of 
the CRP result, only for a bacterial infection to develop without any antibiotic cover. 
Despite these shortfalls clinicians working in primary care with POCT for CRP held 
positive views about using CRP to guide clinical decision making (Wood et al, 2011). 
This was further reported by Anthierens et al (2014) and Cals et al (2009b) where 
clinicians felt that the CRP test decreased clinical uncertainty and supported non-
prescribing decisions. 
Patients’ Perspectives 
Patients were equally as positive when asked about the inclusion of POCT for CRP 
in primary care. Wood et al (2011) reports that patients felt the test gave the clinician 
a better chance of accurate diagnosis and therefore a more accurate management 
plan. These sentiments were echoed by Jones et al (2013) where clinicians 
described enhanced relationships with the patients and a more inclusive decision 
making process. Findings from Cals et al (2013) suggest that enhanced patient 
understanding and stronger patient-clinician relationships as a result of POCT for 
CRP may contribute to a reduction in follow up visits post LRTI. The authors 
concede that this trend is not statistically significant however it stands to reason that 
patients will gain a better understanding of their own illness in the context of their 
CRP result. Historically antibiotics would have been prescribed in the majority of 
acute cough presentations (Meropol, Localio and Metlay, 2013) thereby justifying the 
action of requesting a consultation. If however they had a negative CRP on their last 
consultation, they may perceive the need to seek professional advice less of a 
priority until their symptoms felt worse than the previous episode. Further research is 
needed to confirm whether or not CRP testing is influential in patient behaviour in 
this manner, and whether this may inadvertently increase the risk of patients not 
seeking medical advice when it is more appropriate to do so.  
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Financial Feasibility 
In a climate of economic uncertainty and budget cuts to healthcare systems around 
the world (John & Price, 2013) the cost effectiveness of POCT for CRP must also be 
considered. In a costing statement NICE estimates the total initial spend on 
equipment for GP surgeries in England to be £3.8m. Each subsequent test would 
cost £13.50 when staff time, reagents and calibration are taken into consideration 
(NICE, 2014). Hunter (2015) investigated the potential cost effectiveness of CRP 
POCT in the UK by analysing data collected by Cals et al (2013), Huang et al (2013) 
and Little et al (2013). The cost of prescriptions, adverse events, training costs and 
quality-adjusted life years (QALYs) were all considered over a three year period. 
Whilst the data from these studies has primarily been acquired from European health 
care systems and therefore may not be directly applicable to UK prescription 
practices, Hunter (2015) concludes that CRP POCT would be cost effective within 
the NHS. In the study the initial costs of CRP testing were outweighed by reduction 
in prescriptions, reduction in attendances and increased QALY outcomes. The 
author concedes that the increase in QALY outcomes post intervention were largely 
based on a reduction of follow up attendances for acute cough over a three year 
period in Cals et al (2013). This reduction could have been caused by patients 
perceiving that they would not receive any antibiotics due to the new CRP 
procedure, therefore they may have chosen not to attend despite having cough 
symptoms. If this was the case it would have reduced their QALY scores thereby 
affecting the outcome of the study. Additionally the study uses data from Huang et al 
(2013) for analysis which as discussed in a previous paragraph has been criticised 
for its data collection techniques in the literature (Aabenhus, Cals and Jenson, 
2014).  
A second cost analysis was conducted in Norway and Sweden on behalf of the 
GRACE consortium, again utilising parameters such as QALYs, cost of testing, and 
cost of prescriptions for analysis (Oppong et al, 2013). The authors concluded that 
using CRP POCTs significantly raised the overall costs of managing patients with 
LRTI however this was deemed acceptable based on an increase in QALYs. The 
original data used in this study was sourced from Butler et al (2009) of which the 
primary outcome measure was related to prescribing trends across Europe and not 
primarily concerned with CRP testing. The practices from Norway and Sweden had 
already established the use of CRP POCT in primary care and only displayed a 
reduction in prescriptions of 5% between the CRP test group and the no CRP test 
group. Studies based in countries that had previously not had CRP testing have 
demonstrated a much larger reduction of 15%-22% of prescriptions (Little et al, 
2013; Cals et al 2009a) which is likely to result in greater cost savings. One aspect 
that appears to have been overlooked by both of these economic evaluations is the 
potential reduction in radiological imaging which was demonstrated in a Russian 
study. Andreeva and Melbye (2014) reported a reduction of referral for chest x-ray of 
20% in patients assessed with CRP POCT in primary care, with no adverse 
outcomes reported. This has significant implications for reducing unnecessary 
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radiological exposure, reduced transportation costs to secondary care centres and 
the cost of the imaging itself. The studies also concede that it is difficult to quantify 
the economic value of reducing prescriptions in relation to AMR. In theory reducing 
AMR will have significant implications for cost savings. Targeted therapy and early 
detection of disease is likely to result in reduced admissions, less repeat antibiotic 
prescriptions and fewer investigations. 
Conclusion 
In conclusion the use of CRP POCT within the primary care environment in the UK 
remains controversial. The accuracy of CRP for ruling in or ruling out CAP in primary 
care is not well defined at present, although hospital based studies would suggest 
that it may be of value in the presence of other clinical signs. The delay of CRP 
reaching its peak levels and false positive or false negative results are further 
limitations of the test in primary care. Despite these limitations, current evidence 
suggests that CRP testing can significantly reduce prescriptions for acute cough 
presentations within primary care. These results were achieved with few reported 
adverse events which would indicate CRP POCT is relatively safe to implement. The 
majority of the research was primarily conducted in European healthcare systems 
therefore prospective randomised control trials are required in the UK to draw any 
definitive conclusions. Clinician and patient perceptions of the intervention were 
primarily positive and indicate that it could strengthen the clinician-patient 
relationship. This could have further implications on how often patients choose to 
seek professional advice for acute cough symptoms although further research is 
needed to confirm this. Whether the use of CRP POCT is cost effective is also 
debated in the literature. The studies included in this article did not attempt to 
quantify the economic benefits of reducing the incidence of AMR and overlooked the 
benefit of reduction in imaging in their analysis. Taking these factors into account it is 
likely that CRP POCT will be cost effective in primary care, although data acquired 
from a UK based study would be beneficial for analysis. 
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